Ńîąóĺú´«Ă˝Ň•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • Ńîąóĺú´«Ă˝Ň•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

WHAT'S NEW

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 12 2021

Full Issue

Perspectives: Drug Prices Are Sometimes A Life-Or-Death Situation

Read recent commentaries about drug-cost issues.

Years ago, Maine seniors boarded buses to Canada, where they purchased lower-cost prescription medications. Now, patients young and old skip doses of essential prescriptions that they struggle to afford, sometimes with tragic consequences. High prescription drug prices have been in the headlines for at least a generation. Some important steps have been taken to lower the costs of some medications. Yet, far too many Americans struggle to afford the medication they need, in some cases very literally to survive. (5/10)

Medicare beneficiaries have been among the hardest-hit populations by the pandemic for the last 13 months — about eight in 10 COVID-19 deaths were among people 65 and older. But the pandemic is not the first or only crisis our nation’s older adults have faced over the last several years. Seniors who depend on the Medicare Part D drug benefit are also the most likely to need life-saving prescriptions that they can’t afford. It has been 15 years since the Part D prescription drug benefit was created, and although the program is popular, it has not kept pace with the needs of patients with life-threatening, chronic and rare diseases. The Medicare Part D benefit requires thoughtful updates to ensure the more than 46 million people who rely on the program can afford their prescribed medications. (Amy Niles and Michael Ward, 5/7)

Over the past two years, three small locally owned pharmacies in Orange County have closed, largely because of the economic pressures from pharmacy benefit manager (PBM) companies, said Good NeighboRx owner Al Squitieri.  “Orange County, New York, we deserve better than that,” he said.  PBMs are hired by health plans or insurers to negotiate drug prices with manufacturers and distributors, and to negotiate pharmacy pricing. The industry says the negotiations lead to overall lower prescription drug costs. Critics, including Skoufis, say PBMs have not cut costs for health plans or for consumers. (Heather Yakin, 5/7)

Got an extra $300,000 lying around? That’s how much an average couple retiring at age 65 can expect to pay out of pocket for healthcare over the remainder of their lives. That’s the annual estimate courtesy of Fidelity Investments, and it’s up 1.7% from a year ago. Fidelity says single men retiring at 65 can expect to fork over $143,000 in retirement. Because women typically live longer, their figure is $157,000. (Paul Brandus, 5/7)

The Senate had a long debate last Thursday and Friday on SB-175, the Prescription Drug Affordability Review Board bill. No doubt the sponsors’ hearts are in the right place, but…In a nutshell, the bill creates a board of appointed officials with no accountability to the citizens to review prescription drug prices and cap those prices that they believe are too high. This board’s decision carries the weight of the law, each violation results in a $1,000 fine. (Sen. Dennis Hisey, 5/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 22
  • Thursday, June 18
  • Wednesday, June 17
  • Tuesday, June 16
  • Monday, June 15
  • Friday, June 12
More Morning Briefings
RSS Feeds
  • Ńîąóĺú´«Ă˝Ň•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF